Table 2.
Laboratory results of patients at baseline and at 1 and 2 weeks after the initiation of interferon and ribavirin therapy
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | ||
|---|---|---|---|---|---|---|
| Serum creatinine, mg/dl | Baseline | 5.8 | 4.9 | 0.6 | 0.7 | 4.5 |
| Week 1 | 3.9 | 5.4 | 2.9 | 0.7 | 3.5 | |
| Week 2 | 5.7 | 3.8 | 1.7 | 7.3 | ||
| Week 3 | 0.7 | |||||
| Platelet count, × 109/l | Baseline | 290 | 408 | 272 | 74 | 194 |
| Week 1 | 166 | 239 | 408 | 163 | 160 | |
| Week 2 | 233 | 43 | 106 | 234 | ||
| Week 3 | 85 | |||||
| Hemoglobin, g/dl | Baseline | 11.3 | 9.3 | 10.5 | 11.7 | 8.4 |
| Week 1 | 9.3 | 10.2 | 10.7 | 10 | 8.1 | |
| Week 2 | 9.4 | 9.1 | 9.1 | 8.7 | ||
| Week 3 | 8.7 | |||||
| WBC count, × 109/l | Baseline | 12.9 | 5.5 | 6.3 | 9.5 | 32.1 |
| Week 1 | 7.2 | 4.3 | 20 | 10.7 | 15.5 | |
| Week 2 | 25.5 | 2.7 | 5.1 | 28.6 | ||
| Week 3 | 4.7 | |||||
| Lymphocytes (%) | Baseline | 13 | 17 | 8 | 8 | 4 |
| Week 1 | 17 | 18 | 2 | 2 | 19 | |
| Week 2 | 3 | 62 | 3 | 4 | ||
| Week 3 | 13 |